Literature DB >> 2831367

Alpha 1 antitrypsin deficiency due to Pi null: clinical presentation and evidence for molecular heterogeneity.

F J Bamforth1, N A Kalsheker.   

Abstract

The proteinase inhibitor null (Pi-) allele is a rare cause of alpha 1 antitrypsin (AAT) deficiency. In three families, all the subjects with AAT deficiency due to PiZ- presented in early childhood with recurrent chest infections and wheezing presumably related to passive smoking. In Pi- the AAT gene is present and there is no evidence for a gene deletion. In one family a restriction fragment length polymorphism (RFLP) detected with the enzyme XbaI segregates with the Pi- allele. In a family where a consanguineous marriage occurred, the XbaI polymorphism segregates with the normal M1 allele rather than Pi-, suggesting that Pi- may have originated from M1. In contrast, a third family and 20 normal unrelated subjects do not show the RFLP.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2831367      PMCID: PMC1015448          DOI: 10.1136/jmg.25.2.83

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  16 in total

1.  Complete sequence of the cDNA for human alpha 1-antitrypsin and the gene for the S variant.

Authors:  G L Long; T Chandra; S L Woo; E W Davie; K Kurachi
Journal:  Biochemistry       Date:  1984-10-09       Impact factor: 3.162

2.  Prospective study of children with alpha 1-antitrypsin deficiency: eight-year-old follow-up.

Authors:  T Sveger
Journal:  J Pediatr       Date:  1984-01       Impact factor: 4.406

3.  Liver damage in a neonate with alpha-1-antitrypsin deficiency due to phenotype PiZ null (Z-).

Authors:  J Burn; D Dunger; B Lake
Journal:  Arch Dis Child       Date:  1982-04       Impact factor: 3.791

Review 4.  Structure and variation of human alpha 1-antitrypsin.

Authors:  R W Carrell; J O Jeppsson; C B Laurell; S O Brennan; M C Owen; L Vaughan; D R Boswell
Journal:  Nature       Date:  1982-07-22       Impact factor: 49.962

5.  Four-year-old children with alpha 1-antitrypsin deficiency. Clinical follow-up and parental attitudes towards neonatal screening.

Authors:  T Sveger; T Thelin
Journal:  Acta Paediatr Scand       Date:  1981-03

6.  The isolation of a clone for human alpha 1-antitrypsin and the detection of alpha 1-antitrypsin in mRNA from liver and leukocytes.

Authors:  J Rogers; N Kalsheker; S Wallis; A Speer; C H Coutelle; D Woods; S E Humphries
Journal:  Biochem Biophys Res Commun       Date:  1983-10-31       Impact factor: 3.575

7.  Phenotyping alpha-1-antitrypsin (alpha 1-AT) variants by isoelectric focusing in agarose and immunoblotting.

Authors:  N A Kalsheker; J T Warner; G L Watkins
Journal:  Clin Chim Acta       Date:  1985-05-30       Impact factor: 3.786

8.  Alpha 1-antitrypsin deficiency and emphysema caused by homozygous inheritance of non-expressing alpha 1-antitrypsin genes.

Authors:  R I Garver; J F Mornex; T Nukiwa; M Brantly; M Courtney; J P LeCocq; R G Crystal
Journal:  N Engl J Med       Date:  1986-03-20       Impact factor: 91.245

9.  alpha 1-antitrypsin deficiency detection by direct analysis of the mutation in the gene.

Authors:  V J Kidd; R B Wallace; K Itakura; S L Woo
Journal:  Nature       Date:  1983 Jul 21-27       Impact factor: 49.962

10.  Effects of passive smoking on health of children.

Authors:  B G Ferris; J H Ware; C S Berkey; D W Dockery; A Spiro; F E Speizer
Journal:  Environ Health Perspect       Date:  1985-10       Impact factor: 9.031

View more
  3 in total

1.  Molecular characterisation of two alpha-1-antitrypsin deficiency variants: proteinase inhibitor (Pi) Null(Newport) (Gly115----Ser) and (Pi) Z Wrexham (Ser-19----Leu).

Authors:  A Graham; N A Kalsheker; F J Bamforth; C R Newton; A F Markham
Journal:  Hum Genet       Date:  1990-10       Impact factor: 4.132

2.  Molecular characterisation of three alpha-1-antitrypsin deficiency variants: proteinase inhibitor (Pi) nullcardiff (Asp256----Val); PiMmalton (Phe51----deletion) and PiI (Arg39----Cys).

Authors:  A Graham; N A Kalsheker; C R Newton; F J Bamforth; S J Powell; A F Markham
Journal:  Hum Genet       Date:  1989-12       Impact factor: 4.132

Review 3.  Why has it been so difficult to prove the efficacy of alpha-1-antitrypsin replacement therapy? Insights from the study of disease pathogenesis.

Authors:  Jennifer A Dickens; David A Lomas
Journal:  Drug Des Devel Ther       Date:  2011-08-17       Impact factor: 4.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.